Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 52-week efficacy and safety non-inferiority study of fluticasone propionate/salmeterol 250/50 mcg BID [twice daily] delivered by dry powder inhaler (Diskus) versus mometasone furoate/formoterol fumarate 200/10 mcg BID delivered by pressurized metered-dose inhaler in persistent asthmatics previously treated with medium doses of inhaled glucocorticosteroids

Next Previous
X
Search
Trial Profile

A 52-week efficacy and safety non-inferiority study of fluticasone propionate/salmeterol 250/50 mcg BID [twice daily] delivered by dry powder inhaler (Diskus) versus mometasone furoate/formoterol fumarate 200/10 mcg BID delivered by pressurized metered-dose inhaler in persistent asthmatics previously treated with medium doses of inhaled glucocorticosteroids

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Feb 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Registrational; Therapeutic Use
  • Sponsors Organon; Schering-Plough

    • Most Recent Events

    • 20 Oct 2012 This trial has been discontinued in Finland, Estonia, Lithuanina, Latvia, Czech Republic, Germany and Netherlands as reported by European Clinical Trials Database.
    • 29 Jan 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top